Riluzole 1744-22-5 pharmaceutical intermediates
Riluzole, a benzothiazole compound, is the only drug approved by the US Food and Drug Administration (FDA) for the treatment of amyotrophic lateral sclerosis.
It works mainly by regulating glutamate concentration and acting on ion channels.
It has a wide range of pharmacological effects, such as antidepressant, antidepressant, neurotransmitter and so on.
Glutamate antagonists are used for the treatment of motor nerve diseases. For the treatment of amyotrophic lateral sclerosis (ALS)
4-Trifluoromethoxyaniline reacts with NH4CNS in acetic acid, and then reacts with bromine at 5-10 ℃ overnight to obtain the product in 75% yield with melting point of 117-119 ℃
COMPANY INTRODUCTION
JIN DUN CHEMICAL belongs to JIN DUN GROUP. It is a professional enterprise dedicated to the development and production of special (meth)acrylate monomers. The head office is located in Shanghai city, near Hongqiao airport.The R&D center of JIN DUN is located in Ningbo city, Zhejiang province.
JIN DUN CHEMICAL focus on the coating, automobile, electricity and pharmaceutical area, always try best to be the professional supplier of new raw material for the advanced material in coating, automobile chemicals, electricity chemicals and pharmaceutical intermediate.
The EU company of JIN DUN CHEMICAL located at Frankfurt in Germany. It makes us service our customer better in EU, but also takes more valued information for our creation and future developing.
Welcome our customers and friends to visit our company.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View